ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with ADHD (a specific diagnosis using the international medical coding system)
- People who are currently taking methylphenidate medication (a common ADHD medication)
- Children who are between 8 and 12 years old
- Children whose native language is Finnish
Who may not be able to join:
- People who are sensitive to flashing lights
- People who have epilepsy
- People who have been diagnosed with an intellectual disability
- People who have been diagnosed with a pervasive developmental disorder (such as autism spectrum disorder)
- People who have an inflammatory disease of the brain or central nervous system
- People who have severe cerebral palsy (confirm with trial site for specific severity levels)
- People who have had a traumatic brain injury
- People who have a brain tumour
- People who are part of a multiple pregnancy (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Johanna Uusimaa, MD, PhD, Oulu University Hospital
Phone: +3588315 5218
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Epeli (Executive Performance in Everyday LIving) task; ADHD-rating scale IV (ADHD-RS) (parent report); Epeli Questionnaire (parent report); Epeli Questionnaire (child report)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.